HIGHLIGHTS
- who: Lactiplantibacillus plantarum APsulloc and collaborators from the Global Green Research Development Center, Handong Global University, Pohang-si, Gyeongbuk, Korea have published the research work: Effect of Oral Intake of 331261 (GTB1TM) Syndrome: Placebo-Controlled Study, in the Journal: Nutrients 2022, 14, x FOR PEER REVIEW two of /2022/
- what: The aims of the current study, then, were to evaluate the effects of ingesting the probiotic Lp. plantarum APsulloc 331261 on abdominal discomfort, bowel habits, fecal microbiome, and quality of life in patients with IBS-D. The study was undertaken according to a double-blind . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.